Allergic disorders in primary Sjogren's syndrome

被引:0
作者
Tishler, M
Paran, D
Yaron, M
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Rheumatol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
Sjogren's syndrome; allergy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allergic disorders have been described in a variety of connective tissue disorders. Although an association between allergy and primary Sjogren's syndrome has been suggested, it has not been well documented. The purpose of this study was to analyze the prevalence of several types of allergic disorders in a cohort of primary Sjogren's syndrome patients. The presence of an allergic disorder was evaluated by a specific questionnaire in 65 randomly selected primary Sjogren's syndrome patients and was compared to control groups of 67 rheumatoid arthritis patients, 53 patients with rheumatoid arthritis and sicca symptoms, and 31 patients with osteoarthritis. At least one type of allergic manifestation was reported by 42 of the 65 Sjogren's syndrome patients (65%). This rate was significantly higher than each of the three control groups (p<0.01). Only drug allergy and skin contact allergy were found to be more prevalent in Sjogren's syndrome patients than in the control groups (p<0.05). Allergic reactions were more common in Sjogren's syndrome patients who were anti-Re positive (p<0.05). As drug and skin contact allergies are a frequent finding in Sjogren's syndrome patients, obtaining a careful history is needed before prescribing drugs in these patients.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 50 条
  • [21] Emerging drugs for primary Sjogren's syndrome
    Gandolfo, Saviana
    De Vita, Salvatore
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2019, 24 (02) : 121 - 132
  • [22] Ischemic choroidopathy in primary Sjogren's syndrome
    Rapoport, P
    Merle, H
    Smadja, D
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 1998, 76 (05): : 627 - 628
  • [23] Antiovarian antibodies in primary Sjogren’s syndrome
    Kyriaki Euthymiopoulou
    Alexios J. Aletras
    Panagiota Ravazoula
    Anna Niarakis
    Dimitris Daoussis
    Ioannis Antonopoulos
    Stamatis-Nick Liossis
    Andrew P. Andonopoulos
    [J]. Rheumatology International, 2007, 27 : 1149 - 1155
  • [24] Mycophenolate for the treatment of primary Sjogren's syndrome
    Chen, Weiqian
    Lin, Jin
    [J]. JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2020, 8 (03) : 146 - 149
  • [25] Primary Sjogren's Syndrome and Cardiovascular Disease
    Melissaropoulos, Konstantinos
    Bogdanos, Dimitrios
    Dimitroulas, Theodoros
    Sakkas, Lazaros, I
    Kitas, George D.
    Daoussis, Dimitrios
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 447 - 454
  • [26] Cardiac involvement in primary Sjogren's syndrome
    Qin, Li
    Zhang, Yiwen
    Yang, Xiaoqian
    Luo, Qiang
    Wang, Han
    [J]. RHEUMATOLOGY INTERNATIONAL, 2022, 42 (02) : 179 - 189
  • [27] Lymphoma and Lymphomagenesis in Primary Sjogren's Syndrome
    Alunno, Alessia
    Leone, Maria Comasia
    Giacomelli, Roberto
    Gerli, Roberto
    Carubbi, Francesco
    [J]. FRONTIERS IN MEDICINE, 2018, 5
  • [28] Hematologic manifestations of primary Sjogren's syndrome
    Manganelli, P.
    Fietta, P.
    Quaini, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (04) : 438 - 448
  • [29] Mouse Models of Primary Sjogren's Syndrome
    Park, Young-Seok
    Gauna, Adrienne E.
    Cha, Seunghee
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2350 - 2364
  • [30] Malignant lymphoma in primary Sjogren's syndrome
    Voulgarelis, M
    Moutsopoulos, HM
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (10): : 761 - 766